T1	Participants 47 74	bone marrow transplantation
T2	Participants 287 316	marrow transplantation (BMT).
T3	Participants 521 545	patients undergoing BMT.
T4	Participants 611 687	140 patients undergoing either allogeneic (n = 51) or autologous BMT (n = 89